| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intestinal Mucosa | 119 | 2026 | 675 | 21.040 |
Why?
|
| Colitis | 38 | 2026 | 280 | 8.210 |
Why?
|
| Neutrophils | 67 | 2026 | 1118 | 7.690 |
Why?
|
| Hypoxia | 48 | 2024 | 1193 | 5.880 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 39 | 2026 | 294 | 5.850 |
Why?
|
| Colon | 23 | 2026 | 307 | 5.570 |
Why?
|
| Epithelial Cells | 59 | 2026 | 1106 | 5.270 |
Why?
|
| Hypoxia-Inducible Factor 1 | 32 | 2020 | 69 | 5.120 |
Why?
|
| Butyrates | 11 | 2026 | 66 | 4.880 |
Why?
|
| Inflammation | 49 | 2025 | 2870 | 4.440 |
Why?
|
| Inflammatory Bowel Diseases | 21 | 2026 | 365 | 4.290 |
Why?
|
| Gastrointestinal Microbiome | 16 | 2026 | 771 | 3.900 |
Why?
|
| Cell Hypoxia | 38 | 2020 | 248 | 3.640 |
Why?
|
| Tight Junctions | 15 | 2024 | 81 | 3.400 |
Why?
|
| Adenosine | 23 | 2022 | 255 | 3.260 |
Why?
|
| Fatty Acids, Volatile | 6 | 2025 | 60 | 2.620 |
Why?
|
| Mucous Membrane | 13 | 2023 | 128 | 2.530 |
Why?
|
| Wound Healing | 8 | 2026 | 352 | 2.510 |
Why?
|
| Animals | 163 | 2026 | 37948 | 2.380 |
Why?
|
| Oxygen | 19 | 2024 | 984 | 2.380 |
Why?
|
| Endothelium, Vascular | 27 | 2019 | 949 | 2.220 |
Why?
|
| Signal Transduction | 47 | 2026 | 5185 | 2.190 |
Why?
|
| Homeostasis | 15 | 2026 | 639 | 2.150 |
Why?
|
| Crohn Disease | 5 | 2023 | 259 | 2.010 |
Why?
|
| Gastrointestinal Tract | 6 | 2025 | 207 | 1.990 |
Why?
|
| Intestines | 19 | 2023 | 357 | 1.970 |
Why?
|
| Mice | 96 | 2026 | 18261 | 1.880 |
Why?
|
| Immunity, Mucosal | 9 | 2025 | 98 | 1.740 |
Why?
|
| Cell Line | 52 | 2025 | 2821 | 1.720 |
Why?
|
| Mice, Inbred C57BL | 46 | 2026 | 5967 | 1.710 |
Why?
|
| 5'-Nucleotidase | 11 | 2017 | 49 | 1.660 |
Why?
|
| Dextran Sulfate | 17 | 2026 | 93 | 1.650 |
Why?
|
| Immunity, Innate | 10 | 2026 | 843 | 1.600 |
Why?
|
| Mucositis | 4 | 2023 | 20 | 1.580 |
Why?
|
| Cellular Microenvironment | 5 | 2017 | 93 | 1.530 |
Why?
|
| Peroxidase | 3 | 2024 | 167 | 1.500 |
Why?
|
| Gene Expression Regulation | 28 | 2021 | 2591 | 1.450 |
Why?
|
| Disease Models, Animal | 32 | 2026 | 4539 | 1.430 |
Why?
|
| Escherichia coli | 5 | 2026 | 854 | 1.390 |
Why?
|
| Humans | 219 | 2026 | 144667 | 1.340 |
Why?
|
| Receptor, Adenosine A2B | 9 | 2015 | 65 | 1.330 |
Why?
|
| Energy Metabolism | 9 | 2025 | 927 | 1.320 |
Why?
|
| Cells, Cultured | 57 | 2022 | 4110 | 1.320 |
Why?
|
| Antiporters | 2 | 2021 | 22 | 1.280 |
Why?
|
| Acidosis | 4 | 2021 | 105 | 1.270 |
Why?
|
| Interferon-gamma | 16 | 2023 | 781 | 1.260 |
Why?
|
| Membrane Proteins | 18 | 2025 | 1159 | 1.220 |
Why?
|
| Eicosapentaenoic Acid | 4 | 2020 | 36 | 1.210 |
Why?
|
| Tight Junction Proteins | 3 | 2024 | 15 | 1.140 |
Why?
|
| Transcription Factors | 14 | 2022 | 1726 | 1.110 |
Why?
|
| Inflammation Mediators | 7 | 2017 | 503 | 1.100 |
Why?
|
| Mice, Knockout | 30 | 2025 | 3109 | 1.090 |
Why?
|
| Caco-2 Cells | 19 | 2020 | 79 | 1.080 |
Why?
|
| Receptors, Interleukin-10 | 2 | 2018 | 7 | 1.080 |
Why?
|
| Receptors, G-Protein-Coupled | 4 | 2021 | 231 | 1.080 |
Why?
|
| Nucleotides | 4 | 2018 | 130 | 1.070 |
Why?
|
| Cyclic AMP Response Element-Binding Protein | 6 | 2021 | 145 | 1.070 |
Why?
|
| Cullin Proteins | 3 | 2014 | 14 | 1.060 |
Why?
|
| Prolyl-Hydroxylase Inhibitors | 2 | 2021 | 6 | 1.050 |
Why?
|
| Dysbiosis | 2 | 2021 | 187 | 1.040 |
Why?
|
| Cell Movement | 27 | 2018 | 959 | 1.040 |
Why?
|
| Colitis, Ulcerative | 3 | 2024 | 148 | 1.040 |
Why?
|
| Purines | 4 | 2025 | 187 | 1.030 |
Why?
|
| Bacteria | 5 | 2021 | 894 | 1.030 |
Why?
|
| Transcription, Genetic | 14 | 2019 | 1468 | 1.020 |
Why?
|
| Microfilament Proteins | 5 | 2020 | 136 | 0.990 |
Why?
|
| Inulin | 1 | 2026 | 12 | 0.960 |
Why?
|
| Organoids | 2 | 2025 | 139 | 0.950 |
Why?
|
| Fluorescein-5-isothiocyanate | 2 | 2025 | 36 | 0.940 |
Why?
|
| Gastrointestinal Diseases | 4 | 2025 | 217 | 0.920 |
Why?
|
| Creatine | 4 | 2023 | 63 | 0.910 |
Why?
|
| Ileitis | 3 | 2024 | 33 | 0.910 |
Why?
|
| Neutrophil Activation | 6 | 2019 | 84 | 0.910 |
Why?
|
| Indoles | 2 | 2021 | 504 | 0.910 |
Why?
|
| Cell Adhesion Molecules | 11 | 2020 | 178 | 0.900 |
Why?
|
| Leukocytes | 8 | 2018 | 294 | 0.830 |
Why?
|
| Creatine Kinase | 3 | 2025 | 72 | 0.820 |
Why?
|
| Cell Communication | 12 | 2022 | 325 | 0.810 |
Why?
|
| Permeability | 10 | 2025 | 169 | 0.810 |
Why?
|
| Heme Oxygenase-1 | 3 | 2025 | 74 | 0.800 |
Why?
|
| Fluorescent Dyes | 1 | 2025 | 333 | 0.800 |
Why?
|
| Chemotaxis, Leukocyte | 14 | 2012 | 113 | 0.790 |
Why?
|
| Cell Membrane Permeability | 7 | 2017 | 87 | 0.790 |
Why?
|
| Antigens, CD1 | 11 | 2004 | 60 | 0.780 |
Why?
|
| Tumor Necrosis Factor-alpha | 13 | 2024 | 1207 | 0.780 |
Why?
|
| Blood Proteins | 5 | 2006 | 230 | 0.770 |
Why?
|
| Antigens, CD | 14 | 2008 | 552 | 0.760 |
Why?
|
| Pyrophosphatases | 2 | 2018 | 26 | 0.760 |
Why?
|
| Cell Adhesion | 22 | 2022 | 452 | 0.750 |
Why?
|
| Promoter Regions, Genetic | 19 | 2020 | 1246 | 0.740 |
Why?
|
| Salmonella Infections | 2 | 2022 | 60 | 0.740 |
Why?
|
| Aryl Hydrocarbon Receptor Nuclear Translocator | 2 | 2013 | 19 | 0.740 |
Why?
|
| DNA-Binding Proteins | 12 | 2008 | 1484 | 0.740 |
Why?
|
| Oxidation-Reduction | 5 | 2026 | 1078 | 0.730 |
Why?
|
| Antimicrobial Cationic Peptides | 7 | 2017 | 81 | 0.710 |
Why?
|
| Adenosine Triphosphate | 9 | 2025 | 501 | 0.710 |
Why?
|
| Procollagen-Proline Dioxygenase | 8 | 2011 | 27 | 0.700 |
Why?
|
| Capillary Permeability | 5 | 2009 | 132 | 0.690 |
Why?
|
| Diet, Paleolithic | 1 | 2021 | 2 | 0.690 |
Why?
|
| Endothelial Cells | 8 | 2013 | 864 | 0.680 |
Why?
|
| Bystander Effect | 1 | 2021 | 19 | 0.670 |
Why?
|
| Nuclear Proteins | 9 | 2004 | 741 | 0.670 |
Why?
|
| Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2021 | 21 | 0.660 |
Why?
|
| Ubiquitins | 3 | 2014 | 31 | 0.650 |
Why?
|
| Chemokines | 4 | 2018 | 218 | 0.640 |
Why?
|
| Intestinal Diseases | 2 | 2011 | 42 | 0.640 |
Why?
|
| Lipopolysaccharides | 10 | 2013 | 854 | 0.640 |
Why?
|
| Platelet Membrane Glycoproteins | 3 | 2020 | 30 | 0.640 |
Why?
|
| Plasma Membrane Neurotransmitter Transport Proteins | 1 | 2020 | 6 | 0.640 |
Why?
|
| Immunomodulation | 2 | 2020 | 98 | 0.640 |
Why?
|
| Eosinophils | 7 | 2026 | 316 | 0.640 |
Why?
|
| Autophagy-Related Proteins | 1 | 2020 | 46 | 0.630 |
Why?
|
| Tryptophan | 3 | 2023 | 175 | 0.610 |
Why?
|
| Interleukin-10 Receptor alpha Subunit | 2 | 2017 | 5 | 0.610 |
Why?
|
| Vesicular Transport Proteins | 1 | 2020 | 85 | 0.610 |
Why?
|
| Hydrogen Peroxide | 1 | 2021 | 334 | 0.600 |
Why?
|
| Hypoxanthine | 2 | 2024 | 11 | 0.600 |
Why?
|
| Interleukin-6 | 5 | 2025 | 770 | 0.600 |
Why?
|
| Bacteroides | 1 | 2019 | 20 | 0.590 |
Why?
|
| Corrinoids | 1 | 2019 | 7 | 0.590 |
Why?
|
| HeLa Cells | 11 | 2020 | 632 | 0.590 |
Why?
|
| Phosphoproteins | 5 | 2009 | 339 | 0.590 |
Why?
|
| Lipoxins | 9 | 2005 | 10 | 0.590 |
Why?
|
| Vitamin B Complex | 1 | 2019 | 40 | 0.580 |
Why?
|
| Membrane Transport Proteins | 1 | 2020 | 153 | 0.580 |
Why?
|
| Cell Cycle Proteins | 3 | 2016 | 628 | 0.570 |
Why?
|
| Polyphosphates | 1 | 2018 | 45 | 0.560 |
Why?
|
| Dietary Supplements | 2 | 2021 | 575 | 0.560 |
Why?
|
| Gene Knockdown Techniques | 6 | 2020 | 334 | 0.550 |
Why?
|
| Vitamin B 12 | 1 | 2019 | 127 | 0.550 |
Why?
|
| Phosphoric Diester Hydrolases | 1 | 2018 | 53 | 0.550 |
Why?
|
| Transcriptional Activation | 12 | 2017 | 372 | 0.540 |
Why?
|
| Bacteroidaceae | 1 | 2017 | 3 | 0.530 |
Why?
|
| Citrobacter rodentium | 1 | 2017 | 6 | 0.530 |
Why?
|
| Bacteria, Anaerobic | 1 | 2017 | 25 | 0.520 |
Why?
|
| Intraepithelial Lymphocytes | 1 | 2017 | 16 | 0.520 |
Why?
|
| Microbiota | 3 | 2023 | 782 | 0.520 |
Why?
|
| Cytokines | 9 | 2023 | 2045 | 0.510 |
Why?
|
| Enterobacteriaceae Infections | 1 | 2017 | 42 | 0.510 |
Why?
|
| Prolyl Hydroxylases | 2 | 2014 | 6 | 0.500 |
Why?
|
| Oxygen Consumption | 7 | 2018 | 717 | 0.500 |
Why?
|
| CD55 Antigens | 4 | 2007 | 28 | 0.500 |
Why?
|
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2017 | 48 | 0.500 |
Why?
|
| Down-Regulation | 8 | 2017 | 616 | 0.500 |
Why?
|
| RNA, Messenger | 21 | 2022 | 2815 | 0.500 |
Why?
|
| Immunity | 1 | 2017 | 139 | 0.500 |
Why?
|
| Transendothelial and Transepithelial Migration | 5 | 2019 | 30 | 0.490 |
Why?
|
| Apyrase | 5 | 2008 | 26 | 0.490 |
Why?
|
| Receptors, Purinergic P1 | 5 | 2011 | 31 | 0.490 |
Why?
|
| DNA Primers | 9 | 2013 | 507 | 0.480 |
Why?
|
| Adaptation, Physiological | 4 | 2019 | 567 | 0.480 |
Why?
|
| Nerve Tissue Proteins | 1 | 2020 | 590 | 0.480 |
Why?
|
| CD18 Antigens | 8 | 2007 | 21 | 0.480 |
Why?
|
| Endopeptidases | 2 | 2014 | 79 | 0.480 |
Why?
|
| Gastroenteritis | 1 | 2017 | 63 | 0.480 |
Why?
|
| Alprostadil | 2 | 2013 | 29 | 0.480 |
Why?
|
| NF-kappa B | 11 | 2019 | 657 | 0.470 |
Why?
|
| Interleukin-10 | 6 | 2017 | 310 | 0.470 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 8 | 2003 | 35 | 0.460 |
Why?
|
| Salmonella | 1 | 2016 | 61 | 0.460 |
Why?
|
| Chlorides | 10 | 1998 | 142 | 0.460 |
Why?
|
| Cyclic AMP | 8 | 2002 | 205 | 0.460 |
Why?
|
| Intercellular Adhesion Molecule-1 | 8 | 2008 | 129 | 0.450 |
Why?
|
| Protein Processing, Post-Translational | 4 | 2016 | 466 | 0.450 |
Why?
|
| Ischemia | 4 | 2014 | 422 | 0.450 |
Why?
|
| Host-Pathogen Interactions | 4 | 2020 | 369 | 0.440 |
Why?
|
| Up-Regulation | 9 | 2019 | 848 | 0.440 |
Why?
|
| Inflammasomes | 3 | 2020 | 145 | 0.430 |
Why?
|
| Oxidative Stress | 5 | 2026 | 1338 | 0.420 |
Why?
|
| Cyclooxygenase 2 | 7 | 2026 | 166 | 0.420 |
Why?
|
| Blood Platelets | 4 | 2008 | 379 | 0.410 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 2013 | 268 | 0.410 |
Why?
|
| Adenocarcinoma | 1 | 2021 | 923 | 0.400 |
Why?
|
| Mucins | 2 | 2006 | 75 | 0.400 |
Why?
|
| Blotting, Western | 14 | 2016 | 1161 | 0.400 |
Why?
|
| Genes, MDR | 2 | 2004 | 3 | 0.390 |
Why?
|
| Ileum | 3 | 2024 | 112 | 0.390 |
Why?
|
| Cell Membrane | 10 | 2009 | 706 | 0.390 |
Why?
|
| Isoenzymes | 6 | 2009 | 297 | 0.390 |
Why?
|
| Epithelium | 21 | 2011 | 310 | 0.390 |
Why?
|
| beta-Defensins | 1 | 2013 | 22 | 0.390 |
Why?
|
| Halogenation | 2 | 2024 | 23 | 0.380 |
Why?
|
| Colorectal Neoplasms | 1 | 2021 | 849 | 0.380 |
Why?
|
| A Kinase Anchor Proteins | 1 | 2013 | 70 | 0.380 |
Why?
|
| Pharmaceutical Preparations | 1 | 2014 | 170 | 0.380 |
Why?
|
| Gene Expression | 9 | 2020 | 1476 | 0.370 |
Why?
|
| Acute Lung Injury | 5 | 2017 | 301 | 0.370 |
Why?
|
| Models, Biological | 10 | 2016 | 1811 | 0.360 |
Why?
|
| Autacoids | 1 | 2011 | 1 | 0.350 |
Why?
|
| Dextrans | 3 | 2025 | 86 | 0.350 |
Why?
|
| Phosphorylation | 7 | 2021 | 1704 | 0.350 |
Why?
|
| Body Fluids | 1 | 2012 | 71 | 0.350 |
Why?
|
| Bacterial Translocation | 1 | 2012 | 52 | 0.350 |
Why?
|
| Disease Susceptibility | 4 | 2020 | 342 | 0.350 |
Why?
|
| Chediak-Higashi Syndrome | 4 | 1992 | 7 | 0.340 |
Why?
|
| Bile Acids and Salts | 2 | 2024 | 163 | 0.340 |
Why?
|
| Hydrogen-Ion Concentration | 3 | 2022 | 562 | 0.340 |
Why?
|
| Enzyme Inhibitors | 4 | 2008 | 820 | 0.340 |
Why?
|
| Receptors, Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 2011 | 16 | 0.340 |
Why?
|
| Prostaglandin-Endoperoxide Synthases | 5 | 2002 | 75 | 0.340 |
Why?
|
| Adrenomedullin | 1 | 2011 | 5 | 0.340 |
Why?
|
| Base Sequence | 11 | 2008 | 2177 | 0.330 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 10 | 2012 | 973 | 0.330 |
Why?
|
| 6-Ketoprostaglandin F1 alpha | 2 | 2002 | 17 | 0.320 |
Why?
|
| Chlorine | 2 | 2012 | 62 | 0.320 |
Why?
|
| Fibrosis | 2 | 2023 | 547 | 0.310 |
Why?
|
| Metabolomics | 2 | 2018 | 724 | 0.310 |
Why?
|
| Salmonella enterica | 3 | 2022 | 59 | 0.310 |
Why?
|
| Reactive Oxygen Species | 2 | 2026 | 601 | 0.310 |
Why?
|
| Alkaline Phosphatase | 1 | 2010 | 144 | 0.300 |
Why?
|
| Gram-Positive Bacteria | 1 | 2009 | 49 | 0.300 |
Why?
|
| Adenosine Monophosphate | 5 | 2011 | 86 | 0.300 |
Why?
|
| Monocytes | 3 | 2021 | 536 | 0.300 |
Why?
|
| Extracellular Matrix | 2 | 2006 | 560 | 0.290 |
Why?
|
| Paracrine Communication | 2 | 2000 | 67 | 0.290 |
Why?
|
| Cysteine Endopeptidases | 2 | 2000 | 69 | 0.290 |
Why?
|
| Multienzyme Complexes | 2 | 2000 | 65 | 0.290 |
Why?
|
| Myeloid Cells | 1 | 2010 | 146 | 0.290 |
Why?
|
| Microcirculation | 6 | 2012 | 141 | 0.290 |
Why?
|
| Integrin beta1 | 1 | 2008 | 33 | 0.290 |
Why?
|
| Sp1 Transcription Factor | 1 | 2008 | 24 | 0.280 |
Why?
|
| Immunity, Cellular | 1 | 2010 | 272 | 0.270 |
Why?
|
| Interleukin-8 | 6 | 2005 | 269 | 0.270 |
Why?
|
| Cell Line, Tumor | 8 | 2018 | 3523 | 0.270 |
Why?
|
| Aspirin | 6 | 2007 | 402 | 0.270 |
Why?
|
| Male | 38 | 2025 | 72431 | 0.270 |
Why?
|
| Lung | 11 | 2021 | 4089 | 0.260 |
Why?
|
| Myocardial Reperfusion Injury | 1 | 2008 | 139 | 0.260 |
Why?
|
| Liver | 7 | 2024 | 1889 | 0.260 |
Why?
|
| Claudin-1 | 2 | 2019 | 15 | 0.260 |
Why?
|
| Heme | 4 | 2025 | 89 | 0.260 |
Why?
|
| Sodium-Potassium-Chloride Symporters | 2 | 2008 | 9 | 0.260 |
Why?
|
| Repressor Proteins | 1 | 2011 | 428 | 0.260 |
Why?
|
| Cholestasis | 2 | 2020 | 213 | 0.260 |
Why?
|
| Adenosine Deaminase | 2 | 2013 | 43 | 0.260 |
Why?
|
| Interferon-alpha | 1 | 2008 | 194 | 0.250 |
Why?
|
| STAT3 Transcription Factor | 4 | 2021 | 205 | 0.250 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 3 | 2002 | 125 | 0.250 |
Why?
|
| Female | 35 | 2024 | 78304 | 0.250 |
Why?
|
| Cat Diseases | 3 | 1992 | 25 | 0.250 |
Why?
|
| Symbiosis | 2 | 2017 | 81 | 0.250 |
Why?
|
| Mutagenesis, Site-Directed | 5 | 2015 | 374 | 0.240 |
Why?
|
| Connexin 43 | 1 | 2006 | 36 | 0.240 |
Why?
|
| Umbilical Veins | 5 | 2002 | 56 | 0.240 |
Why?
|
| Tumor Cells, Cultured | 8 | 2021 | 881 | 0.240 |
Why?
|
| Salmonella typhimurium | 5 | 2018 | 189 | 0.240 |
Why?
|
| Dipeptidyl Peptidase 4 | 1 | 2006 | 15 | 0.240 |
Why?
|
| Fermentation | 1 | 2026 | 32 | 0.240 |
Why?
|
| E-Selectin | 2 | 1996 | 61 | 0.240 |
Why?
|
| Adjuvants, Immunologic | 2 | 2005 | 245 | 0.240 |
Why?
|
| Equilibrative-Nucleoside Transporter 2 | 1 | 2005 | 3 | 0.240 |
Why?
|
| Dinoprostone | 2 | 2026 | 180 | 0.240 |
Why?
|
| Protein Stability | 3 | 2019 | 177 | 0.230 |
Why?
|
| Equilibrative Nucleoside Transporter 1 | 1 | 2005 | 20 | 0.230 |
Why?
|
| Gene Expression Regulation, Neoplastic | 4 | 2015 | 1437 | 0.230 |
Why?
|
| Dietary Fiber | 1 | 2026 | 59 | 0.230 |
Why?
|
| Prebiotics | 1 | 2026 | 28 | 0.230 |
Why?
|
| Interleukins | 2 | 2026 | 248 | 0.230 |
Why?
|
| Adenine Nucleotides | 2 | 2003 | 21 | 0.220 |
Why?
|
| Phosphocreatine | 1 | 2025 | 44 | 0.220 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 7 | 2007 | 338 | 0.220 |
Why?
|
| Anti-Bacterial Agents | 3 | 2022 | 1928 | 0.220 |
Why?
|
| Cholera Toxin | 1 | 2005 | 29 | 0.220 |
Why?
|
| Cell Polarity | 10 | 2013 | 137 | 0.220 |
Why?
|
| Antigen Presentation | 4 | 2003 | 206 | 0.220 |
Why?
|
| Plastics | 1 | 2025 | 50 | 0.220 |
Why?
|
| Vasodilator Agents | 2 | 2009 | 329 | 0.220 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 7 | 2015 | 751 | 0.210 |
Why?
|
| Interleukin-4 | 2 | 1996 | 206 | 0.210 |
Why?
|
| Reperfusion Injury | 3 | 2021 | 296 | 0.210 |
Why?
|
| Intercellular Junctions | 3 | 2002 | 35 | 0.210 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2026 | 218 | 0.210 |
Why?
|
| Myocardial Ischemia | 2 | 2019 | 285 | 0.210 |
Why?
|
| NEDD8 Protein | 2 | 2014 | 2 | 0.210 |
Why?
|
| Drug Resistance, Multiple | 1 | 2004 | 25 | 0.200 |
Why?
|
| Cholangitis, Sclerosing | 2 | 2024 | 60 | 0.200 |
Why?
|
| Eosinophilic Esophagitis | 2 | 2019 | 331 | 0.200 |
Why?
|
| Ventilator-Induced Lung Injury | 3 | 2014 | 61 | 0.200 |
Why?
|
| Carcinogenesis | 1 | 2025 | 227 | 0.200 |
Why?
|
| Colonic Neoplasms | 2 | 2025 | 256 | 0.200 |
Why?
|
| Liver Neoplasms | 2 | 2023 | 777 | 0.200 |
Why?
|
| Cell Proliferation | 5 | 2026 | 2489 | 0.200 |
Why?
|
| Carrier Proteins | 7 | 2010 | 733 | 0.200 |
Why?
|
| Actins | 3 | 2023 | 421 | 0.200 |
Why?
|
| Iron | 2 | 2025 | 358 | 0.200 |
Why?
|
| Administration, Oral | 2 | 2019 | 851 | 0.200 |
Why?
|
| Tyrosine | 2 | 2021 | 219 | 0.200 |
Why?
|
| Immunologic Memory | 1 | 2025 | 366 | 0.190 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2003 | 76 | 0.190 |
Why?
|
| Interleukin-13 | 4 | 2021 | 144 | 0.190 |
Why?
|
| Pneumonia | 3 | 2012 | 629 | 0.190 |
Why?
|
| Kupffer Cells | 2 | 2020 | 52 | 0.190 |
Why?
|
| RNA, Small Interfering | 4 | 2017 | 631 | 0.190 |
Why?
|
| Biological Transport | 4 | 2009 | 418 | 0.190 |
Why?
|
| Lubiprostone | 2 | 2013 | 9 | 0.190 |
Why?
|
| Interleukin-1 | 3 | 2022 | 961 | 0.180 |
Why?
|
| Arthritis, Experimental | 1 | 2023 | 141 | 0.180 |
Why?
|
| Acute Disease | 3 | 2017 | 1029 | 0.180 |
Why?
|
| Adherens Junctions | 2 | 2017 | 24 | 0.180 |
Why?
|
| Fluorescent Antibody Technique | 5 | 2015 | 364 | 0.180 |
Why?
|
| Endotoxemia | 2 | 2013 | 86 | 0.180 |
Why?
|
| Kidney | 3 | 2013 | 1495 | 0.180 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 9 | 2003 | 835 | 0.180 |
Why?
|
| Polymerase Chain Reaction | 3 | 2013 | 1047 | 0.170 |
Why?
|
| Response Elements | 2 | 2020 | 85 | 0.170 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 6 | 2006 | 38 | 0.170 |
Why?
|
| Receptors, Cell Surface | 3 | 2010 | 370 | 0.170 |
Why?
|
| Stem Cells | 1 | 2026 | 621 | 0.170 |
Why?
|
| Peroxisomes | 1 | 2001 | 11 | 0.170 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2021 | 13 | 0.170 |
Why?
|
| Dual Specificity Phosphatase 1 | 1 | 2021 | 23 | 0.170 |
Why?
|
| Myocardial Infarction | 2 | 2008 | 1209 | 0.170 |
Why?
|
| Anti-Inflammatory Agents | 3 | 2014 | 477 | 0.170 |
Why?
|
| Interleukin-1beta | 3 | 2020 | 390 | 0.170 |
Why?
|
| Coculture Techniques | 4 | 2006 | 245 | 0.170 |
Why?
|
| Trinitrobenzenesulfonic Acid | 2 | 2013 | 10 | 0.170 |
Why?
|
| Growth Substances | 1 | 2001 | 138 | 0.170 |
Why?
|
| Molecular Sequence Data | 7 | 2008 | 2909 | 0.170 |
Why?
|
| Neuropeptides | 1 | 2001 | 74 | 0.170 |
Why?
|
| Glycolysis | 2 | 2021 | 341 | 0.170 |
Why?
|
| Receptors, Cytokine | 2 | 2016 | 36 | 0.160 |
Why?
|
| Kinetics | 7 | 2005 | 1602 | 0.160 |
Why?
|
| Mucoproteins | 1 | 2020 | 8 | 0.160 |
Why?
|
| Autocrine Communication | 2 | 2002 | 38 | 0.160 |
Why?
|
| Mitogen-Activated Protein Kinases | 2 | 2021 | 287 | 0.160 |
Why?
|
| Polysaccharide-Lyases | 1 | 2000 | 11 | 0.160 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 2000 | 24 | 0.160 |
Why?
|
| Mammals | 1 | 2022 | 296 | 0.160 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 2 | 2 | 2018 | 8 | 0.160 |
Why?
|
| Blood-Brain Barrier | 1 | 2002 | 155 | 0.160 |
Why?
|
| Adenosine Diphosphate | 3 | 2011 | 83 | 0.160 |
Why?
|
| Proto-Oncogene Proteins c-fos | 1 | 2021 | 194 | 0.160 |
Why?
|
| Endotoxins | 1 | 2021 | 218 | 0.160 |
Why?
|
| Antigens, CD1d | 8 | 2004 | 68 | 0.160 |
Why?
|
| Leukocyte Disorders | 1 | 2019 | 9 | 0.160 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 2019 | 25 | 0.150 |
Why?
|
| Phosphatidylinositol 3-Kinases | 2 | 2002 | 380 | 0.150 |
Why?
|
| Amino Acid Sequence | 5 | 2005 | 2136 | 0.150 |
Why?
|
| Glutamic Acid | 1 | 2002 | 254 | 0.150 |
Why?
|
| T-Lymphocytes, Regulatory | 2 | 2013 | 394 | 0.150 |
Why?
|
| Case-Control Studies | 3 | 2020 | 3603 | 0.150 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2001 | 204 | 0.150 |
Why?
|
| Immune System Diseases | 1 | 2019 | 38 | 0.150 |
Why?
|
| Glucose Intolerance | 1 | 2021 | 142 | 0.150 |
Why?
|
| Flow Cytometry | 6 | 2016 | 1154 | 0.150 |
Why?
|
| Muscle Proteins | 1 | 2001 | 240 | 0.150 |
Why?
|
| Phototherapy | 1 | 2019 | 48 | 0.150 |
Why?
|
| Cecum | 1 | 2019 | 37 | 0.150 |
Why?
|
| Biopsy | 2 | 2020 | 1079 | 0.150 |
Why?
|
| Protein Binding | 3 | 2013 | 2243 | 0.140 |
Why?
|
| Circadian Clocks | 1 | 2019 | 59 | 0.140 |
Why?
|
| Dogs | 3 | 2001 | 438 | 0.140 |
Why?
|
| Receptors, Prostaglandin | 1 | 1998 | 21 | 0.140 |
Why?
|
| Macrophages | 3 | 2023 | 1496 | 0.140 |
Why?
|
| Cystic Fibrosis Transmembrane Conductance Regulator | 2 | 2008 | 371 | 0.140 |
Why?
|
| Nanoparticles | 1 | 2025 | 512 | 0.140 |
Why?
|
| Calcium | 3 | 2002 | 1182 | 0.140 |
Why?
|
| Sequence Analysis, RNA | 1 | 2021 | 442 | 0.140 |
Why?
|
| Dinucleoside Phosphates | 1 | 2018 | 31 | 0.140 |
Why?
|
| Aldehydes | 1 | 2019 | 141 | 0.140 |
Why?
|
| Dactinomycin | 1 | 2018 | 23 | 0.140 |
Why?
|
| Adenosine Triphosphatases | 3 | 2004 | 161 | 0.140 |
Why?
|
| THP-1 Cells | 1 | 2018 | 20 | 0.140 |
Why?
|
| Enzyme Precursors | 2 | 2012 | 15 | 0.140 |
Why?
|
| Chemical and Drug Induced Liver Injury | 1 | 2020 | 137 | 0.140 |
Why?
|
| Neutrophil Infiltration | 5 | 2012 | 104 | 0.140 |
Why?
|
| Mucin-5B | 1 | 2021 | 234 | 0.140 |
Why?
|
| Clinical Trials as Topic | 2 | 2021 | 1056 | 0.140 |
Why?
|
| Binding Sites | 4 | 2021 | 1307 | 0.140 |
Why?
|
| Cell Differentiation | 1 | 2026 | 2037 | 0.140 |
Why?
|
| Collagen | 4 | 2023 | 450 | 0.140 |
Why?
|
| Nucleotides, Cyclic | 1 | 1998 | 22 | 0.140 |
Why?
|
| Guanylate Cyclase | 1 | 1998 | 38 | 0.130 |
Why?
|
| Acetaminophen | 2 | 2020 | 265 | 0.130 |
Why?
|
| Gene Expression Profiling | 5 | 2012 | 1766 | 0.130 |
Why?
|
| Vascular Diseases | 1 | 2021 | 252 | 0.130 |
Why?
|
| Hydroxylation | 2 | 2016 | 49 | 0.130 |
Why?
|
| Water-Electrolyte Balance | 1 | 1998 | 37 | 0.130 |
Why?
|
| Cloning, Molecular | 2 | 2011 | 535 | 0.130 |
Why?
|
| Adenylyl Cyclases | 1 | 1998 | 60 | 0.130 |
Why?
|
| Claudin-2 | 1 | 2017 | 2 | 0.130 |
Why?
|
| Cell Culture Techniques | 3 | 2017 | 372 | 0.130 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 1998 | 85 | 0.130 |
Why?
|
| Claudins | 1 | 2017 | 22 | 0.130 |
Why?
|
| Mitochondria | 2 | 2023 | 984 | 0.130 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2023 | 915 | 0.130 |
Why?
|
| Period Circadian Proteins | 2 | 2019 | 33 | 0.130 |
Why?
|
| Lipids | 1 | 2002 | 706 | 0.120 |
Why?
|
| Recombinant Proteins | 9 | 2013 | 1363 | 0.120 |
Why?
|
| Pulmonary Alveoli | 2 | 2017 | 383 | 0.120 |
Why?
|
| RNA Interference | 4 | 2012 | 473 | 0.120 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2017 | 117 | 0.120 |
Why?
|
| Neovascularization, Physiologic | 2 | 2009 | 191 | 0.120 |
Why?
|
| Organ Specificity | 1 | 2017 | 311 | 0.120 |
Why?
|
| Receptors, Aryl Hydrocarbon | 1 | 2017 | 60 | 0.120 |
Why?
|
| SUMO-1 Protein | 2 | 2009 | 18 | 0.120 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2017 | 176 | 0.120 |
Why?
|
| Clostridium | 1 | 2016 | 19 | 0.120 |
Why?
|
| Models, Animal | 2 | 2013 | 393 | 0.120 |
Why?
|
| Immune System | 1 | 2017 | 178 | 0.120 |
Why?
|
| Kynurenine | 1 | 2017 | 103 | 0.120 |
Why?
|
| Alveolar Epithelial Cells | 1 | 2017 | 120 | 0.120 |
Why?
|
| Dendritic Cells | 1 | 2020 | 498 | 0.120 |
Why?
|
| Liver Diseases | 1 | 2019 | 304 | 0.120 |
Why?
|
| Leukemia | 1 | 2018 | 245 | 0.120 |
Why?
|
| Antigens, Surface | 1 | 1996 | 155 | 0.120 |
Why?
|
| Hypercapnia | 1 | 2016 | 53 | 0.120 |
Why?
|
| Respiratory Mucosa | 3 | 2012 | 322 | 0.120 |
Why?
|
| Histone Deacetylases | 1 | 2017 | 207 | 0.120 |
Why?
|
| Fatty Acids, Omega-3 | 3 | 2002 | 141 | 0.120 |
Why?
|
| Mucus | 1 | 2016 | 74 | 0.120 |
Why?
|
| Docosahexaenoic Acids | 2 | 2007 | 83 | 0.120 |
Why?
|
| Feces | 1 | 2019 | 513 | 0.120 |
Why?
|
| Antioxidants | 1 | 2019 | 546 | 0.110 |
Why?
|
| Disease Management | 1 | 2020 | 650 | 0.110 |
Why?
|
| Purine Nucleosides | 1 | 2015 | 4 | 0.110 |
Why?
|
| Platelet Aggregation | 3 | 1992 | 98 | 0.110 |
Why?
|
| Esophagus | 1 | 2017 | 262 | 0.110 |
Why?
|
| Carbohydrate Metabolism | 1 | 1995 | 58 | 0.110 |
Why?
|
| Virulence | 1 | 2016 | 282 | 0.110 |
Why?
|
| Fluoresceins | 1 | 1995 | 48 | 0.110 |
Why?
|
| Nitric Oxide | 2 | 2010 | 894 | 0.110 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2017 | 564 | 0.110 |
Why?
|
| Cyclopentanes | 1 | 2014 | 18 | 0.110 |
Why?
|
| Cytoplasm | 3 | 2001 | 257 | 0.110 |
Why?
|
| Granulocytes | 2 | 2011 | 81 | 0.110 |
Why?
|
| Arthritis, Rheumatoid | 1 | 2023 | 1170 | 0.110 |
Why?
|
| Stress, Mechanical | 2 | 2014 | 494 | 0.110 |
Why?
|
| Trefoil Factor-2 | 2 | 2006 | 3 | 0.110 |
Why?
|
| Proteasome Endopeptidase Complex | 4 | 2012 | 153 | 0.110 |
Why?
|
| Receptors, Lipoxin | 2 | 2005 | 6 | 0.110 |
Why?
|
| Metabolome | 1 | 2018 | 385 | 0.100 |
Why?
|
| Pituitary Gland | 1 | 2015 | 148 | 0.100 |
Why?
|
| Carbon Dioxide | 1 | 2016 | 239 | 0.100 |
Why?
|
| Protease Inhibitors | 1 | 2014 | 101 | 0.100 |
Why?
|
| NADPH Oxidase 2 | 1 | 2014 | 32 | 0.100 |
Why?
|
| Biomarkers | 3 | 2017 | 4261 | 0.100 |
Why?
|
| Glucose | 2 | 2018 | 1033 | 0.100 |
Why?
|
| Adult | 13 | 2021 | 40489 | 0.100 |
Why?
|
| Microarray Analysis | 1 | 2014 | 116 | 0.100 |
Why?
|
| Leukemia, Promyelocytic, Acute | 2 | 1993 | 8 | 0.100 |
Why?
|
| Zonula Occludens-1 Protein | 3 | 2002 | 16 | 0.100 |
Why?
|
| Genes, Reporter | 4 | 2014 | 276 | 0.100 |
Why?
|
| Immunoprecipitation | 1 | 2013 | 147 | 0.100 |
Why?
|
| Membrane Glycoproteins | 3 | 2014 | 496 | 0.100 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2014 | 187 | 0.100 |
Why?
|
| Periodontitis | 2 | 2004 | 54 | 0.100 |
Why?
|
| Hypertension, Renal | 1 | 2013 | 15 | 0.100 |
Why?
|
| Prognosis | 2 | 2013 | 4312 | 0.100 |
Why?
|
| NADPH Oxidases | 1 | 2014 | 120 | 0.100 |
Why?
|
| Idiopathic Pulmonary Fibrosis | 1 | 2021 | 691 | 0.100 |
Why?
|
| CD11 Antigens | 3 | 2007 | 29 | 0.100 |
Why?
|
| NLR Family, Pyrin Domain-Containing 3 Protein | 3 | 2022 | 168 | 0.090 |
Why?
|
| Bone Marrow Transplantation | 2 | 2010 | 293 | 0.090 |
Why?
|
| Thromboxane-A Synthase | 1 | 1992 | 3 | 0.090 |
Why?
|
| T-Lymphocytes | 5 | 2004 | 1984 | 0.090 |
Why?
|
| Macrophage-1 Antigen | 3 | 1998 | 26 | 0.090 |
Why?
|
| Sepsis | 2 | 2017 | 643 | 0.090 |
Why?
|
| Hepatocytes | 3 | 2023 | 221 | 0.090 |
Why?
|
| Mucin 5AC | 1 | 2012 | 70 | 0.090 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 1992 | 89 | 0.090 |
Why?
|
| In Vitro Techniques | 7 | 2000 | 1046 | 0.090 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2013 | 580 | 0.090 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2016 | 370 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor A | 3 | 2017 | 550 | 0.090 |
Why?
|
| Human Umbilical Vein Endothelial Cells | 1 | 2012 | 106 | 0.090 |
Why?
|
| Electrolytes | 1 | 2012 | 54 | 0.090 |
Why?
|
| Analysis of Variance | 2 | 2013 | 1301 | 0.090 |
Why?
|
| Disease Progression | 2 | 2011 | 2847 | 0.090 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2011 | 29 | 0.090 |
Why?
|
| Forkhead Transcription Factors | 1 | 2012 | 203 | 0.090 |
Why?
|
| Adenosylhomocysteinase | 1 | 2011 | 9 | 0.090 |
Why?
|
| Methionine Adenosyltransferase | 1 | 2011 | 10 | 0.090 |
Why?
|
| Chloride Channel Agonists | 1 | 2012 | 109 | 0.090 |
Why?
|
| Pyridones | 1 | 2013 | 201 | 0.090 |
Why?
|
| Receptors, Adrenomedullin | 1 | 2011 | 1 | 0.080 |
Why?
|
| Pseudomonas aeruginosa | 2 | 2006 | 391 | 0.080 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 2007 | 454 | 0.080 |
Why?
|
| Extracellular Space | 1 | 2011 | 119 | 0.080 |
Why?
|
| Platelet Activating Factor | 2 | 2005 | 45 | 0.080 |
Why?
|
| Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 2011 | 161 | 0.080 |
Why?
|
| Middle Aged | 7 | 2021 | 35971 | 0.080 |
Why?
|
| Metagenome | 1 | 2012 | 149 | 0.080 |
Why?
|
| Mice, Transgenic | 5 | 2019 | 2184 | 0.080 |
Why?
|
| Cats | 4 | 1992 | 228 | 0.080 |
Why?
|
| Pyrimidines | 1 | 2014 | 519 | 0.080 |
Why?
|
| Methylation | 1 | 2011 | 241 | 0.080 |
Why?
|
| Piperazines | 1 | 2013 | 378 | 0.080 |
Why?
|
| U937 Cells | 2 | 2007 | 28 | 0.080 |
Why?
|
| Killer Cells, Natural | 5 | 2004 | 470 | 0.080 |
Why?
|
| Neprilysin | 1 | 2010 | 47 | 0.080 |
Why?
|
| Oligonucleotides, Antisense | 2 | 2004 | 117 | 0.080 |
Why?
|
| Airway Remodeling | 1 | 2010 | 63 | 0.080 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2013 | 426 | 0.080 |
Why?
|
| Insulin Resistance | 1 | 2018 | 1241 | 0.080 |
Why?
|
| Peptides | 3 | 2006 | 989 | 0.080 |
Why?
|
| Cell Migration Inhibition | 5 | 2007 | 16 | 0.080 |
Why?
|
| Chromatin | 2 | 2021 | 554 | 0.080 |
Why?
|
| Leukotriene B4 | 4 | 2004 | 37 | 0.080 |
Why?
|
| Antibody Formation | 1 | 2011 | 291 | 0.080 |
Why?
|
| Blood Vessels | 1 | 2011 | 167 | 0.080 |
Why?
|
| Kidney Failure, Chronic | 1 | 2016 | 597 | 0.080 |
Why?
|
| Transfection | 5 | 2006 | 924 | 0.080 |
Why?
|
| Receptors, Adenosine A2 | 1 | 2009 | 5 | 0.080 |
Why?
|
| Chemotactic Factors | 3 | 2007 | 43 | 0.070 |
Why?
|
| beta Catenin | 1 | 2011 | 252 | 0.070 |
Why?
|
| Gene Deletion | 3 | 2022 | 392 | 0.070 |
Why?
|
| beta 2-Microglobulin | 3 | 2001 | 47 | 0.070 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2016 | 657 | 0.070 |
Why?
|
| Obesity | 2 | 2021 | 3070 | 0.070 |
Why?
|
| ROC Curve | 1 | 2011 | 618 | 0.070 |
Why?
|
| Oxidative Phosphorylation | 1 | 2010 | 209 | 0.070 |
Why?
|
| Immunophenotyping | 1 | 2010 | 318 | 0.070 |
Why?
|
| CD47 Antigen | 3 | 1998 | 42 | 0.070 |
Why?
|
| I-kappa B Proteins | 1 | 2009 | 74 | 0.070 |
Why?
|
| Liver Cirrhosis | 2 | 2024 | 287 | 0.070 |
Why?
|
| Water | 1 | 2012 | 468 | 0.070 |
Why?
|
| Time Factors | 9 | 2008 | 7140 | 0.070 |
Why?
|
| Nylons | 1 | 2008 | 24 | 0.070 |
Why?
|
| Adenine | 1 | 2011 | 337 | 0.070 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2011 | 625 | 0.070 |
Why?
|
| Biodiversity | 1 | 2012 | 425 | 0.070 |
Why?
|
| Phenotype | 4 | 2016 | 3147 | 0.070 |
Why?
|
| Biotinylation | 2 | 2005 | 37 | 0.070 |
Why?
|
| Yersinia Infections | 1 | 2007 | 3 | 0.070 |
Why?
|
| Peyer's Patches | 1 | 2007 | 7 | 0.070 |
Why?
|
| Methacrylates | 1 | 2008 | 119 | 0.070 |
Why?
|
| Pyridines | 1 | 1992 | 603 | 0.070 |
Why?
|
| Histocompatibility Antigens Class I | 2 | 2001 | 202 | 0.070 |
Why?
|
| Siderophores | 1 | 2007 | 13 | 0.070 |
Why?
|
| Sepharose | 2 | 2007 | 32 | 0.070 |
Why?
|
| Drug Carriers | 1 | 2008 | 132 | 0.070 |
Why?
|
| Enterobacteriaceae | 1 | 2007 | 44 | 0.070 |
Why?
|
| CD11c Antigen | 1 | 2007 | 40 | 0.060 |
Why?
|
| CD11b Antigen | 1 | 2007 | 60 | 0.060 |
Why?
|
| Adenosine-5'-(N-ethylcarboxamide) | 2 | 2009 | 9 | 0.060 |
Why?
|
| COP9 Signalosome Complex | 1 | 2007 | 5 | 0.060 |
Why?
|
| Gastrointestinal Agents | 1 | 2007 | 65 | 0.060 |
Why?
|
| Adoptive Transfer | 2 | 2021 | 197 | 0.060 |
Why?
|
| Myocardium | 1 | 2012 | 928 | 0.060 |
Why?
|
| Multigene Family | 1 | 2007 | 210 | 0.060 |
Why?
|
| Eosinophilia | 1 | 2009 | 222 | 0.060 |
Why?
|
| 1-Methyl-3-isobutylxanthine | 2 | 1996 | 24 | 0.060 |
Why?
|
| Colforsin | 2 | 1996 | 47 | 0.060 |
Why?
|
| Solute Carrier Family 12, Member 1 | 1 | 2006 | 2 | 0.060 |
Why?
|
| Complement C5 | 1 | 2006 | 33 | 0.060 |
Why?
|
| Dexamethasone | 1 | 2008 | 366 | 0.060 |
Why?
|
| Cervix Uteri | 1 | 2006 | 50 | 0.060 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 1 | 2006 | 85 | 0.060 |
Why?
|
| In Situ Hybridization | 3 | 2002 | 318 | 0.060 |
Why?
|
| Peptide Hydrolases | 1 | 2007 | 105 | 0.060 |
Why?
|
| Antibodies, Monoclonal | 4 | 2006 | 1505 | 0.060 |
Why?
|
| Cattle | 3 | 2003 | 975 | 0.060 |
Why?
|
| Sp Transcription Factors | 1 | 2005 | 3 | 0.060 |
Why?
|
| Drug Delivery Systems | 1 | 2009 | 380 | 0.060 |
Why?
|
| DNA Methylation | 1 | 2011 | 664 | 0.060 |
Why?
|
| Blood Bactericidal Activity | 1 | 2005 | 38 | 0.060 |
Why?
|
| Biological Transport, Active | 1 | 2005 | 69 | 0.060 |
Why?
|
| Enterococcus faecalis | 3 | 1992 | 29 | 0.060 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2005 | 37 | 0.060 |
Why?
|
| Eicosanoids | 2 | 2003 | 58 | 0.060 |
Why?
|
| HLA Antigens | 3 | 2001 | 235 | 0.060 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2007 | 376 | 0.060 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 2117 | 0.060 |
Why?
|
| Consensus Sequence | 1 | 2005 | 73 | 0.060 |
Why?
|
| Lipid Peroxidation | 1 | 2025 | 163 | 0.060 |
Why?
|
| Receptors, Formyl Peptide | 2 | 2003 | 17 | 0.060 |
Why?
|
| Polyethylene Terephthalates | 1 | 2025 | 21 | 0.060 |
Why?
|
| Electric Impedance | 2 | 2017 | 110 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2016 | 2201 | 0.050 |
Why?
|
| Triazines | 1 | 2004 | 49 | 0.050 |
Why?
|
| Biological Factors | 2 | 2002 | 39 | 0.050 |
Why?
|
| Lymphocytes | 2 | 1997 | 379 | 0.050 |
Why?
|
| Diacylglycerol Kinase | 1 | 2004 | 5 | 0.050 |
Why?
|
| Drug Synergism | 1 | 2005 | 352 | 0.050 |
Why?
|
| Protein Subunits | 1 | 2005 | 228 | 0.050 |
Why?
|
| Diet | 1 | 2012 | 1270 | 0.050 |
Why?
|
| Intracellular Fluid | 1 | 2004 | 25 | 0.050 |
Why?
|
| Allopurinol | 1 | 2024 | 70 | 0.050 |
Why?
|
| Arachidonate 15-Lipoxygenase | 1 | 2003 | 20 | 0.050 |
Why?
|
| HSP110 Heat-Shock Proteins | 1 | 2003 | 1 | 0.050 |
Why?
|
| Transforming Growth Factor beta | 3 | 2012 | 475 | 0.050 |
Why?
|
| Diglycerides | 1 | 2004 | 59 | 0.050 |
Why?
|
| Endothelium | 2 | 2002 | 119 | 0.050 |
Why?
|
| Molecular Structure | 2 | 2002 | 495 | 0.050 |
Why?
|
| Paneth Cells | 1 | 2023 | 20 | 0.050 |
Why?
|
| Microscopy, Confocal | 2 | 2002 | 317 | 0.050 |
Why?
|
| Hepatic Stellate Cells | 1 | 2023 | 14 | 0.050 |
Why?
|
| Mice, Mutant Strains | 3 | 2010 | 300 | 0.050 |
Why?
|
| Cell Death | 1 | 2025 | 382 | 0.050 |
Why?
|
| Culture Media, Conditioned | 3 | 1998 | 111 | 0.050 |
Why?
|
| Triazoles | 1 | 2004 | 184 | 0.050 |
Why?
|
| Interleukin-17 | 1 | 2023 | 118 | 0.050 |
Why?
|
| Hydrolysis | 1 | 2003 | 198 | 0.050 |
Why?
|
| Diterpenes | 1 | 2002 | 26 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2011 | 2922 | 0.050 |
Why?
|
| Pulmonary Disease, Chronic Obstructive | 1 | 2010 | 919 | 0.050 |
Why?
|
| Brain Ischemia | 1 | 2006 | 358 | 0.050 |
Why?
|
| Necrosis | 1 | 2023 | 243 | 0.050 |
Why?
|
| Precipitin Tests | 5 | 2003 | 90 | 0.050 |
Why?
|
| Nucleosides | 1 | 2022 | 25 | 0.050 |
Why?
|
| NADH Dehydrogenase | 1 | 2022 | 20 | 0.050 |
Why?
|
| Chromatin Immunoprecipitation | 2 | 2015 | 138 | 0.050 |
Why?
|
| Guanosine Triphosphate | 1 | 2022 | 89 | 0.040 |
Why?
|
| Receptors, HIV | 1 | 2002 | 23 | 0.040 |
Why?
|
| Receptors, Glutamate | 1 | 2002 | 26 | 0.040 |
Why?
|
| Macrophages, Peritoneal | 1 | 2002 | 89 | 0.040 |
Why?
|
| Digestive System | 1 | 2002 | 29 | 0.040 |
Why?
|
| Cell Survival | 3 | 2015 | 1092 | 0.040 |
Why?
|
| Enzyme Induction | 1 | 2002 | 88 | 0.040 |
Why?
|
| Chelating Agents | 1 | 2002 | 72 | 0.040 |
Why?
|
| Immunologic Surveillance | 1 | 2002 | 25 | 0.040 |
Why?
|
| beta-Galactosidase | 1 | 2002 | 76 | 0.040 |
Why?
|
| Urothelium | 1 | 2002 | 33 | 0.040 |
Why?
|
| Trefoil Factor-3 | 1 | 2001 | 5 | 0.040 |
Why?
|
| Syk Kinase | 1 | 2001 | 19 | 0.040 |
Why?
|
| Integrin beta3 | 1 | 2001 | 14 | 0.040 |
Why?
|
| Phosphotyrosine | 1 | 2001 | 38 | 0.040 |
Why?
|
| Stereoisomerism | 3 | 2007 | 102 | 0.040 |
Why?
|
| Androstadienes | 1 | 2001 | 75 | 0.040 |
Why?
|
| Chemotaxis | 2 | 2010 | 123 | 0.040 |
Why?
|
| Skin | 2 | 2003 | 762 | 0.040 |
Why?
|
| Germ-Free Life | 1 | 2021 | 33 | 0.040 |
Why?
|
| A549 Cells | 1 | 2021 | 75 | 0.040 |
Why?
|
| Gain of Function Mutation | 1 | 2021 | 34 | 0.040 |
Why?
|
| Ursodeoxycholic Acid | 1 | 2020 | 17 | 0.040 |
Why?
|
| Immunoglobulin Fc Fragments | 1 | 2001 | 41 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2021 | 56 | 0.040 |
Why?
|
| Dermis | 1 | 2000 | 31 | 0.040 |
Why?
|
| Colorado | 1 | 2011 | 4558 | 0.040 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2022 | 373 | 0.040 |
Why?
|
| Endpoint Determination | 1 | 2021 | 84 | 0.040 |
Why?
|
| Diarrhea | 1 | 2002 | 192 | 0.040 |
Why?
|
| Major Histocompatibility Complex | 1 | 2001 | 233 | 0.040 |
Why?
|
| Protein Transport | 1 | 2002 | 437 | 0.040 |
Why?
|
| Protein Conformation | 1 | 2003 | 935 | 0.040 |
Why?
|
| Inactivation, Metabolic | 1 | 2020 | 9 | 0.040 |
Why?
|
| Electrophysiology | 2 | 1998 | 218 | 0.040 |
Why?
|
| Hypolipidemic Agents | 1 | 2000 | 89 | 0.040 |
Why?
|
| Healthy Volunteers | 1 | 2021 | 215 | 0.040 |
Why?
|
| Homozygote | 2 | 1992 | 200 | 0.040 |
Why?
|
| Pseudomonas Infections | 1 | 2002 | 230 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 1996 | 2019 | 0.040 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2002 | 337 | 0.040 |
Why?
|
| HT29 Cells | 1 | 1999 | 37 | 0.040 |
Why?
|
| MAP Kinase Signaling System | 1 | 2002 | 306 | 0.040 |
Why?
|
| Intestine, Small | 2 | 1999 | 167 | 0.040 |
Why?
|
| Caspase 1 | 1 | 2020 | 146 | 0.040 |
Why?
|
| Heterozygote | 2 | 1992 | 313 | 0.040 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2021 | 192 | 0.040 |
Why?
|
| Glutathione Transferase | 1 | 2019 | 96 | 0.040 |
Why?
|
| Cell Line, Transformed | 1 | 2019 | 138 | 0.040 |
Why?
|
| Cellular Reprogramming | 1 | 2020 | 99 | 0.040 |
Why?
|
| Mice, Inbred Strains | 3 | 2006 | 396 | 0.040 |
Why?
|
| Enzyme Activation | 1 | 2000 | 762 | 0.040 |
Why?
|
| Cross-Linking Reagents | 1 | 1999 | 197 | 0.040 |
Why?
|
| Carbachol | 1 | 1998 | 17 | 0.040 |
Why?
|
| Lysosomes | 1 | 2019 | 128 | 0.040 |
Why?
|
| Receptors, Complement 3b | 1 | 1999 | 80 | 0.040 |
Why?
|
| Receptors, Interleukin | 2 | 1998 | 43 | 0.040 |
Why?
|
| 8-Bromo Cyclic Adenosine Monophosphate | 1 | 1998 | 18 | 0.040 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2020 | 125 | 0.030 |
Why?
|
| Cell Nucleus | 2 | 2002 | 592 | 0.030 |
Why?
|
| Prostaglandins | 1 | 1998 | 94 | 0.030 |
Why?
|
| Research | 1 | 2002 | 431 | 0.030 |
Why?
|
| Peptide Fragments | 1 | 2002 | 691 | 0.030 |
Why?
|
| Models, Genetic | 1 | 2021 | 531 | 0.030 |
Why?
|
| Horses | 2 | 1989 | 203 | 0.030 |
Why?
|
| Models, Molecular | 1 | 2003 | 1610 | 0.030 |
Why?
|
| Protein-Tyrosine Kinases | 1 | 2001 | 431 | 0.030 |
Why?
|
| Toll-Like Receptor 4 | 1 | 2020 | 277 | 0.030 |
Why?
|
| Thalidomide | 1 | 1998 | 43 | 0.030 |
Why?
|
| Nucleotidases | 1 | 2017 | 6 | 0.030 |
Why?
|
| Cyclic GMP | 1 | 1998 | 90 | 0.030 |
Why?
|
| Epoprostenol | 1 | 1998 | 132 | 0.030 |
Why?
|
| Ribosomes | 1 | 2019 | 196 | 0.030 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 1999 | 365 | 0.030 |
Why?
|
| Receptors, Tumor Necrosis Factor | 1 | 1998 | 161 | 0.030 |
Why?
|
| NAD | 1 | 1998 | 82 | 0.030 |
Why?
|
| Bacterial Load | 1 | 2017 | 67 | 0.030 |
Why?
|
| Nitrates | 1 | 1998 | 100 | 0.030 |
Why?
|
| Superoxide Dismutase | 1 | 2019 | 303 | 0.030 |
Why?
|
| RNA Polymerase II | 1 | 2021 | 351 | 0.030 |
Why?
|
| Bacterial Adhesion | 2 | 1998 | 110 | 0.030 |
Why?
|
| CD3 Complex | 1 | 1997 | 111 | 0.030 |
Why?
|
| Rats | 3 | 2017 | 5570 | 0.030 |
Why?
|
| Chemokine CXCL12 | 1 | 2017 | 86 | 0.030 |
Why?
|
| Mice, Inbred BALB C | 3 | 2007 | 1251 | 0.030 |
Why?
|
| Diet, High-Fat | 1 | 2018 | 261 | 0.030 |
Why?
|
| Receptors, CXCR4 | 1 | 2017 | 91 | 0.030 |
Why?
|
| Thionucleotides | 1 | 1996 | 35 | 0.030 |
Why?
|
| Anemia | 2 | 2016 | 189 | 0.030 |
Why?
|
| Molecular Probes | 1 | 1996 | 33 | 0.030 |
Why?
|
| Weight Loss | 1 | 2022 | 839 | 0.030 |
Why?
|
| Hepatitis, Viral, Human | 1 | 2016 | 20 | 0.030 |
Why?
|
| Integrin beta Chains | 1 | 2016 | 7 | 0.030 |
Why?
|
| Complement C3 | 1 | 1997 | 192 | 0.030 |
Why?
|
| Leukosialin | 1 | 2016 | 12 | 0.030 |
Why?
|
| HCT116 Cells | 1 | 2016 | 78 | 0.030 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1996 | 113 | 0.030 |
Why?
|
| Epigenesis, Genetic | 1 | 2021 | 669 | 0.030 |
Why?
|
| Chromatography, Liquid | 3 | 2006 | 444 | 0.030 |
Why?
|
| Tetradecanoylphorbol Acetate | 2 | 1993 | 150 | 0.030 |
Why?
|
| Leukocyte Common Antigens | 1 | 2016 | 87 | 0.030 |
Why?
|
| Ligands | 3 | 2008 | 662 | 0.030 |
Why?
|
| L-Selectin | 1 | 1995 | 27 | 0.030 |
Why?
|
| Neuraminidase | 1 | 1995 | 25 | 0.030 |
Why?
|
| Bevacizumab | 1 | 2016 | 168 | 0.030 |
Why?
|
| Antibodies | 1 | 1997 | 396 | 0.030 |
Why?
|
| rho GTP-Binding Proteins | 1 | 1995 | 56 | 0.030 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2015 | 34 | 0.030 |
Why?
|
| Diffusion Chambers, Culture | 1 | 1995 | 9 | 0.030 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2015 | 120 | 0.030 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2016 | 339 | 0.030 |
Why?
|
| Oligonucleotides | 1 | 2016 | 151 | 0.030 |
Why?
|
| Botulinum Toxins | 1 | 1995 | 46 | 0.030 |
Why?
|
| Liver Diseases, Alcoholic | 1 | 2016 | 97 | 0.030 |
Why?
|
| Gonadotrophs | 1 | 2015 | 21 | 0.030 |
Why?
|
| Hypercholesterolemia | 1 | 2016 | 93 | 0.030 |
Why?
|
| GTP-Binding Proteins | 1 | 1995 | 153 | 0.030 |
Why?
|
| Cytoprotection | 1 | 2015 | 55 | 0.030 |
Why?
|
| Cytoskeleton | 1 | 1996 | 197 | 0.030 |
Why?
|
| Protein Structure, Secondary | 1 | 1996 | 365 | 0.030 |
Why?
|
| Immunoblotting | 2 | 2011 | 293 | 0.030 |
Why?
|
| Receptors, Mitogen | 1 | 1994 | 7 | 0.030 |
Why?
|
| Receptors, Interleukin-4 | 1 | 1994 | 16 | 0.030 |
Why?
|
| Mutant Proteins | 1 | 2015 | 104 | 0.030 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2016 | 96 | 0.030 |
Why?
|
| Gene Amplification | 1 | 2015 | 119 | 0.030 |
Why?
|
| Mass Spectrometry | 3 | 2006 | 743 | 0.030 |
Why?
|
| Apoptosis | 2 | 2015 | 2397 | 0.030 |
Why?
|
| Nonlinear Dynamics | 1 | 1995 | 96 | 0.030 |
Why?
|
| Suppressor of Cytokine Signaling 3 Protein | 1 | 2013 | 11 | 0.030 |
Why?
|
| Complement Activation | 1 | 1997 | 409 | 0.030 |
Why?
|
| Cadherins | 2 | 2011 | 200 | 0.030 |
Why?
|
| DNA Copy Number Variations | 1 | 2015 | 184 | 0.030 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2013 | 20 | 0.030 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2015 | 265 | 0.030 |
Why?
|
| Lymphocyte Activation | 1 | 1997 | 1124 | 0.020 |
Why?
|
| Fatty Liver | 1 | 2016 | 250 | 0.020 |
Why?
|
| Aorta | 1 | 1996 | 427 | 0.020 |
Why?
|
| Ribonucleotides | 1 | 1993 | 26 | 0.020 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2021 | 2137 | 0.020 |
Why?
|
| Esters | 2 | 2003 | 72 | 0.020 |
Why?
|
| Chronic Disease | 2 | 2013 | 1810 | 0.020 |
Why?
|
| Molecular Targeted Therapy | 1 | 2016 | 437 | 0.020 |
Why?
|
| Pituitary Neoplasms | 1 | 2015 | 190 | 0.020 |
Why?
|
| Mice, 129 Strain | 1 | 2013 | 84 | 0.020 |
Why?
|
| GPI-Linked Proteins | 1 | 2013 | 81 | 0.020 |
Why?
|
| Angiotensin II | 1 | 2013 | 95 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2015 | 435 | 0.020 |
Why?
|
| Jurkat Cells | 1 | 2012 | 114 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2015 | 849 | 0.020 |
Why?
|
| Platelet Count | 1 | 1992 | 94 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 1992 | 168 | 0.020 |
Why?
|
| Proteomics | 1 | 2019 | 1183 | 0.020 |
Why?
|
| Arachidonic Acid | 1 | 1992 | 101 | 0.020 |
Why?
|
| Vasoconstrictor Agents | 1 | 2013 | 144 | 0.020 |
Why?
|
| Zymosan | 1 | 1992 | 39 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2021 | 2350 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 1993 | 564 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 1992 | 315 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 2016 | 374 | 0.020 |
Why?
|
| Atherosclerosis | 1 | 2016 | 409 | 0.020 |
Why?
|
| Health | 1 | 2012 | 81 | 0.020 |
Why?
|
| Endothelin-1 | 1 | 2013 | 181 | 0.020 |
Why?
|
| Platelet Storage Pool Deficiency | 1 | 1991 | 2 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 2015 | 451 | 0.020 |
Why?
|
| Phagocytes | 1 | 1992 | 79 | 0.020 |
Why?
|
| Cyclosporins | 1 | 1991 | 71 | 0.020 |
Why?
|
| Cell Degranulation | 2 | 2003 | 41 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2017 | 689 | 0.020 |
Why?
|
| Microsomes | 2 | 2000 | 33 | 0.020 |
Why?
|
| Whole-Body Irradiation | 1 | 1991 | 73 | 0.020 |
Why?
|
| Mycoplasma Infections | 1 | 1990 | 17 | 0.020 |
Why?
|
| Phagocytosis | 1 | 1992 | 296 | 0.020 |
Why?
|
| Camelids, New World | 1 | 1990 | 9 | 0.020 |
Why?
|
| Furans | 1 | 2010 | 27 | 0.020 |
Why?
|
| Microscopy, Electron | 1 | 1991 | 413 | 0.020 |
Why?
|
| Child | 3 | 2019 | 22600 | 0.020 |
Why?
|
| Adenosine A2 Receptor Antagonists | 1 | 2010 | 14 | 0.020 |
Why?
|
| Adenosine A2 Receptor Agonists | 1 | 2010 | 24 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2021 | 5957 | 0.020 |
Why?
|
| Acetamides | 1 | 2010 | 38 | 0.020 |
Why?
|
| Thiophenes | 1 | 2010 | 121 | 0.020 |
Why?
|
| Amino Acids, Dicarboxylic | 1 | 2009 | 9 | 0.020 |
Why?
|
| Brain | 1 | 2002 | 2934 | 0.020 |
Why?
|
| Purinergic P1 Receptor Agonists | 1 | 2009 | 8 | 0.020 |
Why?
|
| Platelet Endothelial Cell Adhesion Molecule-1 | 1 | 2009 | 49 | 0.020 |
Why?
|
| Aminopyridines | 1 | 2010 | 129 | 0.020 |
Why?
|
| NF-KappaB Inhibitor alpha | 1 | 2009 | 49 | 0.020 |
Why?
|
| Eosinophil Cationic Protein | 1 | 2009 | 9 | 0.020 |
Why?
|
| Luciferases | 1 | 2009 | 152 | 0.020 |
Why?
|
| Homeodomain Proteins | 1 | 2013 | 523 | 0.020 |
Why?
|
| Graft vs Host Disease | 1 | 1991 | 263 | 0.020 |
Why?
|
| Solute Carrier Family 12, Member 2 | 1 | 2008 | 7 | 0.020 |
Why?
|
| Adolescent | 3 | 2019 | 22409 | 0.020 |
Why?
|
| Smoking | 1 | 2016 | 1467 | 0.020 |
Why?
|
| Administration, Inhalation | 1 | 2010 | 570 | 0.020 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2009 | 221 | 0.020 |
Why?
|
| Receptors, Immunologic | 2 | 2001 | 206 | 0.020 |
Why?
|
| Guinea Pigs | 2 | 2002 | 160 | 0.020 |
Why?
|
| CD8 Antigens | 2 | 2001 | 70 | 0.020 |
Why?
|
| Yersinia enterocolitica | 1 | 2007 | 7 | 0.020 |
Why?
|
| Enterobacter aerogenes | 1 | 2007 | 3 | 0.020 |
Why?
|
| T-Lymphocyte Subsets | 2 | 2004 | 412 | 0.020 |
Why?
|
| Molecular Weight | 2 | 2000 | 312 | 0.020 |
Why?
|
| Hydroxamic Acids | 1 | 2007 | 94 | 0.020 |
Why?
|
| Insulin | 1 | 2018 | 2502 | 0.020 |
Why?
|
| Hypertension | 1 | 2016 | 1262 | 0.020 |
Why?
|
| Thiazoles | 1 | 2007 | 139 | 0.020 |
Why?
|
| Phenols | 1 | 2007 | 107 | 0.020 |
Why?
|
| Inosine | 1 | 2006 | 14 | 0.020 |
Why?
|
| Complement C3-C5 Convertases | 1 | 2006 | 22 | 0.020 |
Why?
|
| Antibodies, Blocking | 1 | 2006 | 37 | 0.020 |
Why?
|
| Infarction, Middle Cerebral Artery | 1 | 2006 | 42 | 0.010 |
Why?
|
| Brain Edema | 1 | 2006 | 62 | 0.010 |
Why?
|
| Drug Design | 2 | 1998 | 176 | 0.010 |
Why?
|
| Body Temperature | 1 | 2006 | 226 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 2006 | 449 | 0.010 |
Why?
|
| Erythrocytes | 1 | 1990 | 750 | 0.010 |
Why?
|
| Abetalipoproteinemia | 1 | 2004 | 3 | 0.010 |
Why?
|
| Pulmonary Artery | 1 | 2010 | 1124 | 0.010 |
Why?
|
| Lymphoid Tissue | 1 | 2004 | 78 | 0.010 |
Why?
|
| Immunoglobulin G | 2 | 2001 | 886 | 0.010 |
Why?
|
| Integrins | 2 | 1995 | 90 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2019 | 11790 | 0.010 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 2003 | 37 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 2004 | 273 | 0.010 |
Why?
|
| Electric Conductivity | 2 | 1995 | 85 | 0.010 |
Why?
|
| Administration, Topical | 1 | 2003 | 152 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 2004 | 205 | 0.010 |
Why?
|
| DNA | 1 | 2010 | 1447 | 0.010 |
Why?
|
| Gene Silencing | 1 | 2004 | 202 | 0.010 |
Why?
|
| Diabetes Mellitus | 1 | 2012 | 1076 | 0.010 |
Why?
|
| Phthalic Anhydrides | 1 | 2002 | 1 | 0.010 |
Why?
|
| Aged | 2 | 2016 | 25955 | 0.010 |
Why?
|
| Gene Products, tat | 1 | 2003 | 22 | 0.010 |
Why?
|
| Croton Oil | 1 | 2002 | 3 | 0.010 |
Why?
|
| Calcimycin | 1 | 2002 | 36 | 0.010 |
Why?
|
| Hypersensitivity, Delayed | 1 | 2002 | 29 | 0.010 |
Why?
|
| Carboxylic Acids | 1 | 2003 | 33 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 2003 | 203 | 0.010 |
Why?
|
| Animals, Genetically Modified | 1 | 2003 | 245 | 0.010 |
Why?
|
| Terpenes | 1 | 2002 | 25 | 0.010 |
Why?
|
| Iloprost | 1 | 2002 | 45 | 0.010 |
Why?
|
| Administration, Cutaneous | 1 | 2002 | 126 | 0.010 |
Why?
|
| Bacterial Infections | 1 | 2004 | 247 | 0.010 |
Why?
|
| Rabbits | 1 | 2003 | 651 | 0.010 |
Why?
|
| Amino Acid Motifs | 1 | 2003 | 220 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 1705 | 0.010 |
Why?
|
| Lactase-Phlorizin Hydrolase | 1 | 2002 | 2 | 0.010 |
Why?
|
| Lactase | 1 | 2002 | 4 | 0.010 |
Why?
|
| CX3C Chemokine Receptor 1 | 1 | 2002 | 20 | 0.010 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2002 | 20 | 0.010 |
Why?
|
| Body Weight | 1 | 2006 | 968 | 0.010 |
Why?
|
| Endoplasmic Reticulum | 1 | 2004 | 264 | 0.010 |
Why?
|
| MAP Kinase Kinase 1 | 1 | 2002 | 70 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2002 | 126 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2002 | 135 | 0.010 |
Why?
|
| Fluorescent Antibody Technique, Direct | 1 | 2001 | 9 | 0.010 |
Why?
|
| Microscopy, Fluorescence | 1 | 2003 | 407 | 0.010 |
Why?
|
| Buffers | 1 | 2001 | 55 | 0.010 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 2002 | 106 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 2001 | 46 | 0.010 |
Why?
|
| Genes, MHC Class I | 1 | 2001 | 37 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2002 | 171 | 0.010 |
Why?
|
| Receptors, Leukotriene B4 | 1 | 2000 | 7 | 0.010 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2000 | 24 | 0.010 |
Why?
|
| North America | 1 | 2002 | 312 | 0.010 |
Why?
|
| Indomethacin | 1 | 2000 | 76 | 0.010 |
Why?
|
| Receptors, KIR | 1 | 2001 | 114 | 0.010 |
Why?
|
| Cell Division | 1 | 2002 | 753 | 0.010 |
Why?
|
| Stomach Neoplasms | 1 | 2002 | 130 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2012 | 2172 | 0.010 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 2002 | 630 | 0.010 |
Why?
|
| Gastroenterology | 1 | 2002 | 190 | 0.010 |
Why?
|
| Antigen-Antibody Complex | 1 | 1999 | 70 | 0.010 |
Why?
|
| Antibody Specificity | 1 | 1999 | 178 | 0.010 |
Why?
|
| Models, Immunological | 1 | 1999 | 100 | 0.010 |
Why?
|
| Virulence Factors, Bordetella | 1 | 1998 | 15 | 0.010 |
Why?
|
| Pertussis Toxin | 1 | 1998 | 24 | 0.010 |
Why?
|
| Sodium-Hydrogen Exchangers | 1 | 1998 | 23 | 0.010 |
Why?
|
| Receptors, Interleukin-8A | 1 | 1998 | 5 | 0.010 |
Why?
|
| Receptors, Peptide | 1 | 1998 | 18 | 0.010 |
Why?
|
| CD2 Antigens | 1 | 1997 | 6 | 0.010 |
Why?
|
| Receptor-CD3 Complex, Antigen, T-Cell | 1 | 1997 | 9 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2002 | 532 | 0.010 |
Why?
|
| Membrane Cofactor Protein | 1 | 1997 | 14 | 0.010 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2001 | 667 | 0.010 |
Why?
|
| Protein Isoforms | 1 | 1999 | 396 | 0.010 |
Why?
|
| Complement Inactivator Proteins | 1 | 1997 | 39 | 0.010 |
Why?
|
| Societies, Medical | 1 | 2002 | 890 | 0.010 |
Why?
|
| Superoxides | 1 | 1998 | 199 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 1997 | 197 | 0.010 |
Why?
|
| Glycoproteins | 1 | 1999 | 353 | 0.010 |
Why?
|
| Vaccines | 1 | 2002 | 388 | 0.010 |
Why?
|
| Nocodazole | 1 | 1996 | 17 | 0.010 |
Why?
|
| Egtazic Acid | 1 | 1996 | 37 | 0.010 |
Why?
|
| Melanoma | 1 | 2003 | 757 | 0.010 |
Why?
|
| Models, Structural | 1 | 1996 | 41 | 0.010 |
Why?
|
| Surface Properties | 1 | 1997 | 397 | 0.010 |
Why?
|
| rhoC GTP-Binding Protein | 1 | 1995 | 6 | 0.010 |
Why?
|
| ADP Ribose Transferases | 1 | 1995 | 9 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 2009 | 2660 | 0.010 |
Why?
|
| Paclitaxel | 1 | 1996 | 256 | 0.010 |
Why?
|
| Peptides, Cyclic | 1 | 1996 | 275 | 0.010 |
Why?
|
| Glycosylation | 1 | 1994 | 161 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1994 | 324 | 0.010 |
Why?
|
| Theophylline | 1 | 1993 | 41 | 0.010 |
Why?
|
| Microtubules | 1 | 1996 | 287 | 0.010 |
Why?
|
| Young Adult | 1 | 2010 | 14122 | 0.010 |
Why?
|
| Epitopes | 1 | 1995 | 479 | 0.010 |
Why?
|
| Rubidium | 1 | 1992 | 11 | 0.010 |
Why?
|
| Iodine | 1 | 1992 | 27 | 0.010 |
Why?
|
| Mutation | 1 | 2003 | 4081 | 0.010 |
Why?
|
| Abscess | 1 | 1992 | 76 | 0.010 |
Why?
|
| Blood Protein Electrophoresis | 1 | 1990 | 6 | 0.010 |
Why?
|
| Mycoplasma | 1 | 1990 | 5 | 0.010 |
Why?
|
| Blood Cell Count | 1 | 1990 | 55 | 0.010 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 1990 | 200 | 0.000 |
Why?
|
| Blood Chemical Analysis | 1 | 1990 | 109 | 0.000 |
Why?
|
| Immunologic Techniques | 1 | 1989 | 38 | 0.000 |
Why?
|
| Culture Media | 1 | 1989 | 163 | 0.000 |
Why?
|
| Gelatin | 1 | 1989 | 56 | 0.000 |
Why?
|
| Cell Count | 1 | 1989 | 320 | 0.000 |
Why?
|
| Bacterial Proteins | 1 | 1993 | 981 | 0.000 |
Why?
|